Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares traded up 14.3% during mid-day trading on Tuesday . The company traded as high as GBX 2.40 and last traded at GBX 2.40. 738,083 shares were traded during mid-day trading, a decline of 27% from the average session volume of 1,006,172 shares. The stock had previously closed at GBX 2.10.
Cizzle Biotechnology Stock Performance
The company has a market capitalization of £10.31 million, a P/E ratio of -8.13 and a beta of 0.51. The company has a debt-to-equity ratio of -54.35, a current ratio of 0.48 and a quick ratio of 4.66. The business has a 50-day moving average of GBX 1.97 and a 200-day moving average of GBX 1.70.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
